调查格拉姆阴性细菌分离物对塞夫塔齐/阿维巴克坦的敏感性
Sunali1,2, Mithilesh Kumar Jha3, Mukesh Kumar2
1Department of Microbiology, Geetanjali Medical College and Hospital, Udaipur, Rajasthan, India.
Journal of family medicine and primary care
|February 24, 2025
概括
塞法胺-阿维巴克坦对抗多药耐药 (MDR) 格拉姆阴性细菌具有很高的疗效,包括对卡巴耐药的肠道细菌 (CRE). 这种新型抗生素是治疗困难感染的有希望的替代品,特别是尿路感染,其性能优于旧药物.
科学领域:
- 传染性疾病 传染性疾病
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 越来越多的抗药性 (MDR) 格拉姆阴性生物体的流行.
- 耐卡巴胺肠道细菌 (CRE) 构成了全球严重的健康威胁.
- 需要新型抗生素,因为现有治疗方法的局限性,如tigecycline和colistin.
研究的目的:
- 为了评估ceftazidime-avibactam对格拉姆阴性菌根的抗生素敏感性.
- 在印度的临床环境中评估ceftazidime-avibactam的疗效.
- 为了比较ceftazidime-avibactam与其他抗生素对抗MDR和CRE分离物.
主要方法:
- 从临床样本中包括81种格拉姆阴性细菌.
- 使用了Kirby Bauer光盘扩散方法.
- 遵守临床实验室标准研究所 (CLSI) 的指导方针.
主要成果:
- 塞法胺-阿维巴克坦抑制了89.9%的Enterobacteriaceae分离物,超过了阿米卡辛 (80.3%) 和美罗 (85.1%).
- 已证明对CRE分离物 (69.9%) 和MDR尿路感染 (94%) 的有效性.
- 在特定的MDR尿路感染病例中表现优于氏 (40%) 和氏 (94%).
结论:
- 塞法胺-阿维巴克坦是抗MDR和CRE感染的强效药物.
- 与传统抗生素相比,它为尿路感染提供了更好的治疗选择.
- 代表了一种有价值的工具,用于打击抗菌素耐药性.
相关概念视频
Urine Studies II: Urine Culture and Sensitivity Test
A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...


